All-oral shorter treatment regimens for multidrug- and rifampicin- resistant TB (MDR/RR-TB): A single arm prospective observational cohort study evaluating their effectiveness and safety for patients in Sierra Leone

Principal investigator

Lynda Foray
Purpose of study
Purpose of study

To determine the effectiveness and safety of all-oral shorter MDR/RR-TB regimens of 9-12 month duration under operational research conditions in Sierra Leone.

Study status

  • Concept
  • Protocol & ERB
  • Implementation
  • Completion
  • Archived

Study timeline


No publications recorded
Previous study
Next study